Tag: Antiretroviral drugs

While modern antiretroviral therapy (ART) has significantly extended the lifespan of people living with HIV, studies show that older medications like tenofovir disoproxil fumarate (TDF) can contribute to kidney damage. This guide will explore the question of whether antiretroviral drugs cause kidney failure, outlining the specific risks associated with certain medications and advancements that have made treatment safer.

Over 39 million people globally are living with HIV, and antiretroviral therapy (ART) has transformed the virus into a manageable chronic condition, but a key concern for patients is what are the two most common adverse effects of antiretroviral drugs. The most frequently reported issues are short-term gastrointestinal problems and central nervous system effects, particularly during the initial phase of treatment.

With antiretroviral therapy (ART), the rate of serious anemia in HIV patients has dropped significantly, yet a substantial number of individuals still experience mild-to-moderate cases. Understanding *which antiretroviral drugs cause anemia* is crucial for effective patient management and improving quality of life.

Over 90% of HIV-infected patients starting treatment now use regimens that contain an integrase strand transfer inhibitor. Understanding **what is the mechanism of integrase** is crucial for appreciating how these modern antiretroviral drugs effectively halt viral replication by preventing the virus from permanently altering the host cell's DNA.

As of 2025, an estimated 28 million people globally are receiving antiretroviral therapy (ART) to manage HIV. Two cornerstone classes of these life-saving drugs are NRTIs and NNRTIs. Understanding **what is the difference between NRTI and Nnrti** is crucial to appreciating how modern combination therapies work to control the virus.

According to the CDC, post-exposure prophylaxis (PEP) can reduce the risk of HIV infection by more than 80% when taken correctly. To achieve this, PEP involves a combination of powerful antiretroviral drugs that must be started within 72 hours of a potential exposure. Understanding what drugs are part of PEP is the first step in seeking this emergency prevention method.

Studies show that a significant portion of people living with HIV (PLHIV) on antiretroviral therapy (ART) experience potential drug-drug interactions, with some estimates ranging from 21.4% to over 50% [1.7.1, 1.7.3, 1.7.5]. Understanding what to avoid when taking antiretroviral drugs is crucial for treatment success and preventing adverse effects.

Antiretroviral therapy (ART) has dramatically changed HIV from a fatal diagnosis to a manageable chronic condition, largely due to the development of **ARV**, or antiretroviral drugs. These medications are the backbone of modern HIV treatment and prevention strategies, giving the immune system a chance to recover by controlling viral replication.

Reydin is one of many brand names for a recommended first-line antiretroviral therapy (ART) used to treat HIV-1. So, what is another name for Reydin? This medication is more broadly known as TLD, a fixed-dose combination of three separate drugs.

Over 10,000 HIV-positive individuals on tenofovir disoproxil fumarate (TDF) showed an increased risk for chronic kidney disease. This highlights that a major side effect of tenofovir, particularly the older TDF formulation, is renal and bone toxicity, which necessitates careful monitoring and management by healthcare professionals.